Menu

Search

  |   Business

Menu

  |   Business

Search

Teewinot Life Sciences Engages NetworkNewsWire for Corporate Communications Solutions

NEW YORK, Feb. 07, 2018 -- via NetworkWire - Teewinot Life Sciences Corporation, an international biopharmaceutical company employing its patent-protected CannSynthesis® technology to biosynthesize cannabinoids for the large-scale manufacture of pharmaceutically pure cannabinoids, announces that it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

“Teewinot enjoys a commercial first-mover advantage in the field of cannabinoid biosynthesis with patents covering biosynthetic processes and equipment for the manufacture of cannabinoids, as well as water-soluble cannabinoid formulation technology. As we work to expand our patent portfolio, we are pleased to partner with NNW to raise brand visibility and enhance our external communications,” says Teewinot president, director and CEO Jeffrey M. Korentur.

NNW is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. NNW’s strategies help public and private organizations find their voice and build market visibility. As part of the Client-Partner relationship with Teewinot, NNW will leverage its investor-based distribution network of over 5,000 key syndication outlets, various newsletters, social media channels, blogs, and other outreach tools to generate greater brand awareness for the Company.

“Teewinot Life Sciences is committed to innovative research that unlocks the medicinal properties found within the cannabis plant,” states Sherri Franklin, director of Content Marketing for NNW. “We look forward to assisting the company with a corporate communications campaign to assist the company with its brand awareness.”

About Teewinot Life Sciences Corporation

Teewinot Life Sciences Corporation is an international cannabinoid biopharmaceutical company focused on advanced pharmaceutical research and product development. Teewinot’s novel platform manufacturing technology enables the production and delivery of products containing cannabinoids, cannabinoid prodrugs, and cannabinoid analogs. With headquarters in Tampa, Florida, and subsidiaries, Teewinot Technologies Ltd. in Ireland and Teewinot Laboratories, Inc. in Canada, The Teewinot Group’s revolutionary technologies and intellectual property portfolio represent a breakthrough in creating safe and standardized cannabinoids. For more information, visit the company’s website at www.TLSCorp.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge. For more information, please visit https://www.NetworkNewsWire.com.

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Primary Logo

  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.